|
||||||||
|
Volume 5: No. 3, July 2008
ORIGINAL RESEARCH
|
Age, y | Rate per 100,000 | |||
---|---|---|---|---|
All races | White | Black | Asian/Pacific Islander | |
20-24 | 0.1 | 0.1 | 0.2 | 0.4 |
25-29 | 0.2 | 0.1 | 0.4 | 1.1 |
30-34 | 0.3 | 0.2 | 0.7 | 2.1 |
35-39 | 0.8 | 0.4 | 1.5 | 5.3 |
40-44 | 2.3 | 1.8 | 3.8 | 8.5 |
45-49 | 7.5 | 6.1 | 14.0 | 18.9 |
50-54 | 11.0 | 8.9 | 23.0 | 27.1 |
55-59 | 12.3 | 10.0 | 23.5 | 37.2 |
60-64 | 15.1 | 12.5 | 22.6 | 56.0 |
65-69 | 20.6 | 18.0 | 26.1 | 71.1 |
70-74 | 24.1 | 21.6 | 31.8 | 75.2 |
75-79 | 27.0 | 25.2 | 27.6 | 80.0 |
80-84 | 23.2 | 21.7 | 24.7 | 70.6 |
≥85 | 17.9 | 16.6 | 19.7 | 57.9 |
Women, by Race
Age, y | Rate per 100,000 | |||
---|---|---|---|---|
All races | White | Black | Asian/Pacific Islander | |
20-24 | 0.1 | 0.1 | 0.1 | 0.4 |
25-29 | 0.1 | 0.1 | 0.1 | 0.1 |
30-34 | 0.1 | 0.1 | 0.2 | 0.5 |
35-39 | 0.2 | 0.2 | 0.5 | 0.6 |
40-44 | 0.5 | 0.3 | 1.0 | 1.6 |
45-49 | 1.2 | 1.0 | 2.0 | 2.4 |
50-54 | 1.7 | 1.4 | 2.9 | 4.6 |
55-59 | 2.6 | 2.1 | 4.4 | 7.3 |
60-64 | 4.2 | 3.4 | 5.9 | 18.2 |
65-69 | 6.5 | 5.2 | 8.2 | 30.1 |
70-74 | 8.1 | 7.0 | 10.9 | 33.2 |
75-79 | 8.8 | 7.8 | 11.6 | 30.7 |
80-84 | 8.6 | 7.8 | 10.3 | 34.5 |
≥85 | 6.1 | 5.9 | 5.5 | 19.8 |
Men and Women, by Ethnicity
Age, y | Rate per 100,000 | |||
---|---|---|---|---|
Hispanic men | Non-Hispanic men | Hispanic women | Non-Hispanic women | |
20-24 | 0.1 | 0.1 | 0 | 0.1 |
25-29 | 0.1 | 0.2 | 0.1 | 0.1 |
30-34 | 0.3 | 0.4 | 0.1 | 0.2 |
35-39 | 0.7 | 0.8 | 0.2 | 0.2 |
40-44 | 3.5 | 2.2 | 0.4 | 0.5 |
45-49 | 13.8 | 6.8 | 1.7 | 1.1 |
50-54 | 19.6 | 10.2 | 2.7 | 1.7 |
55-59 | 27.1 | 11.1 | 5.9 | 2.3 |
60-64 | 31.5 | 13.9 | 9.7 | 3.8 |
65-69 | 46.3 | 18.7 | 15.8 | 5.8 |
70-74 | 49.6 | 22.5 | 19.8 | 7.4 |
75-79 | 60.6 | 25.2 | 26.6 | 7.8 |
80-84 | 44.7 | 22.3 | 24.0 | 8.0 |
≥85 | 40.7 | 16.8 | 22.5 | 5.5 |
Figure 1. Age-Specific Incidence of Hepatocellular
Carcinoma, by Patients’ Sex and Race/Ethnicity, United States, 1998–2003.
Data cover 83% of the U.S. population and are from population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program and that met study criteria.
Characteristic | APC | |
---|---|---|
Male | Female | |
Race/Ethnicity | ||
White | 4.8a | 4.5a |
Black | 6.0a | 1.7 |
Asian/Pacific Islander | 0.4 | 1.2 |
Hispanic | 3.6a | 1.8 |
Age, y | ||
<45 | -0.6 | -1.6 |
45-59 | 9.0a | 9.0a |
60-74 | 3.6a | 3.2a |
≥75 | 2.6a | 3.8a |
Region | ||
Midwest | 3.6a | 2.9 |
South | 5.9a | 5.2a |
Northeast | 6.2a | 5.9a |
West | 3.3a | 3.0 |
Race/Ethnicity (Among Those Aged 45-59 y) | ||
White | 10.4a | 9.5a |
Black | 8.9a | 12.3a |
Asian/Pacific Islander | -2.7 | -0.3 |
Hispanic | 8.8a | 3.5 |
Figure 2. Annual Percentage Change (APC) in Incidence
of Hepatocellular Carcinoma, United States, 1998–2003.
Data cover 83% of the U.S. population and are from population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program and that met study criteria.
a P < .05 indicates that the APC is significantly greater than zero.
|
|
|
|
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Privacy Policy | Accessibility This page last reviewed October 25, 2011
|
|